Other languages Pfizer Limited

Equities

PFIZER

INE182A01018

Delayed NSE India S.E. Other stock markets 07:43:49 2024-05-02 am EDT			5-day change	1st Jan Change
4,277 ^INR	+0.47%		+3.02%	+0.19%

Apr. 02	Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer	CI
Apr. 02	Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance	Apr. 02
China's National Medical Products Administration Accepts Astellas and Pfizer's Supplemental Biologics License Application for Enfortumab Vedotin with Keytruda (Pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer	Mar. 28
Pfizer Limited Informs Satyen Amin, Lead - Market Access Tenders His Resignation from Employment, with Effect from March 31, 2024	Feb. 09
Pfizer Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 09
Pfizer Ltd. Names CFO	Jan. 21
Pfizer CFO Retires	Dec. 01
Pfizer Limited Appoints Ms. Aditi Mehta as Category Lead, Vaccines Effective December 1, 2023	Nov. 16
Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023	Nov. 13
Pfizer Sees Sharp Fall in Fiscal Q2 Net Profit	23-10-30
Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors	23-10-28
Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-28
Pfizer Limited Appoints Chaitanya Nadkarni as India Digital Client Partner Lead	23-09-06
Pfizer Limited Approves A Final Dividend for the Financial Year Ended March 31, 2023	23-08-21
Pfizer Limited Announces Change in Management, Effective September 1, 2023	23-08-18
Seagen's breast cancer therapy meets main goal in late-stage study	23-08-16
Pfizer Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11
Pfizer Limited Proposes Final Dividend for the Financial Year Ended March 31, 2023	23-07-27
Pfizer Limited Initiates Voluntary Recall Of Magnex 1gm, 2gm, Magnex Forte 1.5gm, 3gm, Zosyn 4.5gm and Magnamycin 250mg, 1gm, 2gm Injections	23-05-18
Pfizer Posts Higher Fiscal Q4 Net Profit	23-05-16
Pfizer's India unit posts 3% rise in Q4 profit	23-05-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pfizer Limited

Equities

PFIZER

INE182A01018

Other languages

Filters